These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 19117052)
21. Semaphorin-plexin signalling genes associated with human breast tumourigenesis. Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246 [TBL] [Abstract][Full Text] [Related]
22. Transcriptome analysis reveals an osteoblast-like phenotype for human osteotropic breast cancer cells. Bellahcène A; Bachelier R; Detry C; Lidereau R; Clézardin P; Castronovo V Breast Cancer Res Treat; 2007 Jan; 101(2):135-48. PubMed ID: 17028989 [TBL] [Abstract][Full Text] [Related]
23. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis. Merdad A; Karim S; Schulten HJ; Dallol A; Buhmeida A; Al-Thubaity F; Gari MA; Chaudhary AG; Abuzenadah AM; Al-Qahtani MH Anticancer Res; 2014 Mar; 34(3):1355-66. PubMed ID: 24596383 [TBL] [Abstract][Full Text] [Related]
24. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray]. Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993 [TBL] [Abstract][Full Text] [Related]
25. Identification of the functional role of AF1Q in the progression of breast cancer. Chang XZ; Li DQ; Hou YF; Wu J; Lu JS; Di GH; Jin W; Ou ZL; Shen ZZ; Shao ZM Breast Cancer Res Treat; 2008 Sep; 111(1):65-78. PubMed ID: 17929166 [TBL] [Abstract][Full Text] [Related]
26. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors. Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003 [TBL] [Abstract][Full Text] [Related]
27. Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases. Tabariès S; Ouellet V; Hsu BE; Annis MG; Rose AA; Meunier L; Carmona E; Tam CE; Mes-Masson AM; Siegel PM Breast Cancer Res; 2015 Mar; 17(1):45. PubMed ID: 25882816 [TBL] [Abstract][Full Text] [Related]
28. FOXP3 suppresses breast cancer metastasis through downregulation of CD44. Zhang C; Xu Y; Hao Q; Wang S; Li H; Li J; Gao Y; Li M; Li W; Xue X; Wu S; Zhang Y; Zhang W Int J Cancer; 2015 Sep; 137(6):1279-90. PubMed ID: 25683728 [TBL] [Abstract][Full Text] [Related]
29. Functional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer. Johnstone CN; Smith YE; Cao Y; Burrows AD; Cross RS; Ling X; Redvers RP; Doherty JP; Eckhardt BL; Natoli AL; Restall CM; Lucas E; Pearson HB; Deb S; Britt KL; Rizzitelli A; Li J; Harmey JH; Pouliot N; Anderson RL Dis Model Mech; 2015 Mar; 8(3):237-51. PubMed ID: 25633981 [TBL] [Abstract][Full Text] [Related]
30. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma. Sathyanarayana UG; Padar A; Huang CX; Suzuki M; Shigematsu H; Bekele BN; Gazdar AF Clin Cancer Res; 2003 Dec; 9(17):6389-94. PubMed ID: 14695139 [TBL] [Abstract][Full Text] [Related]
31. mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients. Sieuwerts AM; Mostert B; Bolt-de Vries J; Peeters D; de Jongh FE; Stouthard JM; Dirix LY; van Dam PA; Van Galen A; de Weerd V; Kraan J; van der Spoel P; Ramírez-Moreno R; van Deurzen CH; Smid M; Yu JX; Jiang J; Wang Y; Gratama JW; Sleijfer S; Foekens JA; Martens JW Clin Cancer Res; 2011 Jun; 17(11):3600-18. PubMed ID: 21505063 [TBL] [Abstract][Full Text] [Related]
32. Claudin-2 promotes breast cancer liver metastasis by facilitating tumor cell interactions with hepatocytes. Tabariès S; Dupuy F; Dong Z; Monast A; Annis MG; Spicer J; Ferri LE; Omeroglu A; Basik M; Amir E; Clemons M; Siegel PM Mol Cell Biol; 2012 Aug; 32(15):2979-91. PubMed ID: 22645303 [TBL] [Abstract][Full Text] [Related]
33. Secretomes reveal several novel proteins as well as TGF-β1 as the top upstream regulator of metastatic process in breast cancer. Erin N; Ogan N; Yerlikaya A Breast Cancer Res Treat; 2018 Jul; 170(2):235-250. PubMed ID: 29557524 [TBL] [Abstract][Full Text] [Related]
34. Exon-level transcriptome profiling in murine breast cancer reveals splicing changes specific to tumors with different metastatic abilities. Bemmo A; Dias C; Rose AA; Russo C; Siegel P; Majewski J PLoS One; 2010 Aug; 5(8):e11981. PubMed ID: 20700505 [TBL] [Abstract][Full Text] [Related]
35. Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumor progression. Davidson B; Konstantinovsky S; Nielsen S; Dong HP; Berner A; Vyberg M; Reich R Clin Cancer Res; 2004 Nov; 10(21):7335-46. PubMed ID: 15534110 [TBL] [Abstract][Full Text] [Related]
36. Mechanisms driving local breast cancer recurrence in a model of breast-conserving surgery. Smith MJ; Culhane AC; Killeen S; Kelly MA; Wang JH; Cotter TG; Redmond HP Ann Surg Oncol; 2008 Oct; 15(10):2954-64. PubMed ID: 18622646 [TBL] [Abstract][Full Text] [Related]
37. Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer. Parker BS; Ciocca DR; Bidwell BN; Gago FE; Fanelli MA; George J; Slavin JL; Möller A; Steel R; Pouliot N; Eckhardt B; Henderson MA; Anderson RL J Pathol; 2008 Feb; 214(3):337-46. PubMed ID: 17985332 [TBL] [Abstract][Full Text] [Related]
38. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential. Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798 [TBL] [Abstract][Full Text] [Related]
39. Aberrant expression of tumor suppressors CADM1 and 4.1B in invasive lesions of primary breast cancer. Takahashi Y; Iwai M; Kawai T; Arakawa A; Ito T; Sakurai-Yageta M; Ito A; Goto A; Saito M; Kasumi F; Murakami Y Breast Cancer; 2012 Jul; 19(3):242-52. PubMed ID: 21526423 [TBL] [Abstract][Full Text] [Related]
40. Epithelial-mesenchymal transition (EMT) is not sufficient for spontaneous murine breast cancer metastasis. Lou Y; Preobrazhenska O; auf dem Keller U; Sutcliffe M; Barclay L; McDonald PC; Roskelley C; Overall CM; Dedhar S Dev Dyn; 2008 Oct; 237(10):2755-68. PubMed ID: 18773493 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]